<?xml version="1.0" encoding="UTF-8"?>
<xbrli:xbrl xmlns:in-bse-fin="http://www.bseindia.com/xbrl/fin/2020-03-31/in-bse-fin" xmlns:in-bse-fin-roles="http://www.bseindia.com/xbrl/fin/2020-03-31/in-bse-fin-roles" xmlns:in-bse-fin-ent="http://www.bseindia.com/xbrl/fin/2020-03-31/in-bse-fin/in-bse-fin-ent" xmlns:in-bse-fin-type="http://www.bseindia.com/xbrl/fin/2020-03-31/in-bse-fin-types" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink">
<link:schemaRef xlink:type="simple" xlink:href="Ind-AS_entry_point_2020-03-31.xsd"/>
<xbrli:context id="OneD"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="FourD"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="OneOperatingExpenses01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:DetailsOfOtherExpensesAxis">in-bse-fin:OneOperatingExpenses01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourOperatingExpenses01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:DetailsOfOtherExpensesAxis">in-bse-fin:FourOperatingExpenses01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneI"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context>
<xbrli:context id="OneReportableSegmentRevenue01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsAxis">in-bse-fin:OneReportableSegmentRevenue01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentRevenue02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsAxis">in-bse-fin:OneReportableSegmentRevenue02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourReportableSegmentRevenue01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsAxis">in-bse-fin:FourReportableSegmentRevenue01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourReportableSegmentRevenue02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsAxis">in-bse-fin:FourReportableSegmentRevenue02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentResults01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsFinanceCostsAxis">in-bse-fin:OneReportableSegmentResults01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentResults02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsFinanceCostsAxis">in-bse-fin:OneReportableSegmentResults02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourReportableSegmentResults01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsFinanceCostsAxis">in-bse-fin:FourReportableSegmentResults01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourReportableSegmentResults02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentsFinanceCostsAxis">in-bse-fin:FourReportableSegmentResults02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentAssets01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentAssetsAxis">in-bse-fin:OneReportableSegmentAssets01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentAssets02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentAssetsAxis">in-bse-fin:OneReportableSegmentAssets02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentLiabilities01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentLiabilitiesAxis">in-bse-fin:OneReportableSegmentLiabilities01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentLiabilities01I"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentLiabilitiesAxis">in-bse-fin:OneReportableSegmentLiabilities01Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentLiabilities02D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentLiabilitiesAxis">in-bse-fin:OneReportableSegmentLiabilities02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneReportableSegmentLiabilities02I"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-bse-fin:ReportableSegmentLiabilitiesAxis">in-bse-fin:OneReportableSegmentLiabilities02Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneItemsThatWillNotBeReclassifiedToProfitAndLoss01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-bse-fin:ItemsThatWillNotBeReclassifiedToProfitAndLossAxis"><ItemsThatWillNotBeReclassifiedToProfitAndLossDomain>in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member</ItemsThatWillNotBeReclassifiedToProfitAndLossDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourItemsThatWillNotBeReclassifiedToProfitAndLoss01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-bse-fin:ItemsThatWillNotBeReclassifiedToProfitAndLossAxis"><ItemsThatWillNotBeReclassifiedToProfitAndLossDomain>in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member</ItemsThatWillNotBeReclassifiedToProfitAndLossDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context>
<xbrli:context id="OneItemsThatWillBeReclassifiedToProfitAndLoss01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-bse-fin:ItemsThatWillBeReclassifiedToProfitAndLossAxis"><ItemsThatWillBeReclassifiedToProfitAndLossDomain>in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member</ItemsThatWillBeReclassifiedToProfitAndLossDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context>
<xbrli:context id="FourItemsThatWillBeReclassifiedToProfitAndLoss01D"><xbrli:entity><xbrli:identifier scheme="http://www.nseindia.com/NSESymbol">PANACEABIO</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-bse-fin:ItemsThatWillBeReclassifiedToProfitAndLossAxis"><ItemsThatWillBeReclassifiedToProfitAndLossDomain>in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member</ItemsThatWillBeReclassifiedToProfitAndLossDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context>
<xbrli:unit id="INR"><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unit><xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="INRPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<in-bse-fin:ScripCode contextRef="OneD">531349</in-bse-fin:ScripCode>
<in-bse-fin:Symbol contextRef="OneD">PANACEABIO</in-bse-fin:Symbol>
<in-bse-fin:MSEISymbol contextRef="OneD">NOTLISTED</in-bse-fin:MSEISymbol>
<in-bse-fin:NameOfTheCompany contextRef="OneD">Panacea Biotec Limited</in-bse-fin:NameOfTheCompany>
<in-bse-fin:ClassOfSecurity contextRef="OneD">Equity</in-bse-fin:ClassOfSecurity>
<in-bse-fin:DateOfStartOfFinancialYear contextRef="OneD">2022-04-01</in-bse-fin:DateOfStartOfFinancialYear>
<in-bse-fin:DateOfEndOfFinancialYear contextRef="OneD">2023-03-31</in-bse-fin:DateOfEndOfFinancialYear>
<in-bse-fin:DateOfBoardMeetingWhenFinancialResultsWereApproved contextRef="OneD">2023-05-30</in-bse-fin:DateOfBoardMeetingWhenFinancialResultsWereApproved>
<in-bse-fin:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange contextRef="OneD">2023-05-15</in-bse-fin:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange>
<in-bse-fin:DescriptionOfPresentationCurrency contextRef="OneD">INR</in-bse-fin:DescriptionOfPresentationCurrency>
<in-bse-fin:LevelOfRoundingUsedInFinancialStatements contextRef="OneD">Lakhs</in-bse-fin:LevelOfRoundingUsedInFinancialStatements>
<in-bse-fin:ReportingQuarter contextRef="OneD">Yearly</in-bse-fin:ReportingQuarter>
<in-bse-fin:StartTimeOfBoardMeeting contextRef="OneD">11:00:00</in-bse-fin:StartTimeOfBoardMeeting>
<in-bse-fin:EndTimeOfBoardMeeting contextRef="OneD">14:30:00</in-bse-fin:EndTimeOfBoardMeeting>
<in-bse-fin:DateOfStartOfBoardMeeting contextRef="OneD">2023-05-30</in-bse-fin:DateOfStartOfBoardMeeting>
<in-bse-fin:DateOfEndOfBoardMeeting contextRef="OneD">2023-05-30</in-bse-fin:DateOfEndOfBoardMeeting>
<in-bse-fin:WhetherCashFlowStatementIsApplicableOnCompany contextRef="OneD">true</in-bse-fin:WhetherCashFlowStatementIsApplicableOnCompany>
<in-bse-fin:TypeOfCashFlowStatement contextRef="OneD">Cash Flow Indirect</in-bse-fin:TypeOfCashFlowStatement>
<in-bse-fin:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification contextRef="OneD">Declaration of unmodified opinion</in-bse-fin:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification>
<in-bse-fin:IsCompanyReportingMultisegmentOrSingleSegment contextRef="OneD">Multi segment</in-bse-fin:IsCompanyReportingMultisegmentOrSingleSegment>
<in-bse-fin:DateOfStartOfReportingPeriod contextRef="OneD">2023-01-01</in-bse-fin:DateOfStartOfReportingPeriod>
<in-bse-fin:DateOfEndOfReportingPeriod contextRef="OneD">2023-03-31</in-bse-fin:DateOfEndOfReportingPeriod>
<in-bse-fin:WhetherResultsAreAuditedOrUnaudited contextRef="OneD">Audited</in-bse-fin:WhetherResultsAreAuditedOrUnaudited>
<in-bse-fin:NatureOfReportStandaloneConsolidated contextRef="OneD">Consolidated</in-bse-fin:NatureOfReportStandaloneConsolidated>
<in-bse-fin:RevenueFromOperations contextRef="OneD" unitRef="INR" decimals="-5">1289300000.00</in-bse-fin:RevenueFromOperations>
<in-bse-fin:OtherIncome contextRef="OneD" unitRef="INR" decimals="-5">150600000.00</in-bse-fin:OtherIncome>
<in-bse-fin:Income contextRef="OneD" unitRef="INR" decimals="-5">1439900000.00</in-bse-fin:Income>
<in-bse-fin:CostOfMaterialsConsumed contextRef="OneD" unitRef="INR" decimals="-5">595100000.00</in-bse-fin:CostOfMaterialsConsumed>
<in-bse-fin:PurchasesOfStockInTrade contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchasesOfStockInTrade>
<in-bse-fin:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade contextRef="OneD" unitRef="INR" decimals="-5">-20300000.00</in-bse-fin:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade>
<in-bse-fin:EmployeeBenefitExpense contextRef="OneD" unitRef="INR" decimals="-5">305500000.00</in-bse-fin:EmployeeBenefitExpense>
<in-bse-fin:FinanceCosts contextRef="OneD" unitRef="INR" decimals="-5">10500000.00</in-bse-fin:FinanceCosts>
<in-bse-fin:DepreciationDepletionAndAmortisationExpense contextRef="OneD" unitRef="INR" decimals="-5">95100000.00</in-bse-fin:DepreciationDepletionAndAmortisationExpense>
<in-bse-fin:OtherExpenses contextRef="OneD" unitRef="INR" decimals="-5">465700000.00</in-bse-fin:OtherExpenses>
<in-bse-fin:Expenses contextRef="OneD" unitRef="INR" decimals="-5">1451600000.00</in-bse-fin:Expenses>
<in-bse-fin:ProfitBeforeExceptionalItemsAndTax contextRef="OneD" unitRef="INR" decimals="-5">-11700000.00</in-bse-fin:ProfitBeforeExceptionalItemsAndTax>
<in-bse-fin:ExceptionalItemsBeforeTax contextRef="OneD" unitRef="INR" decimals="-5">193800000.00</in-bse-fin:ExceptionalItemsBeforeTax>
<in-bse-fin:ProfitBeforeTax contextRef="OneD" unitRef="INR" decimals="-5">182100000.00</in-bse-fin:ProfitBeforeTax>
<in-bse-fin:CurrentTax contextRef="OneD" unitRef="INR" decimals="-5">25600000.00</in-bse-fin:CurrentTax>
<in-bse-fin:DeferredTax contextRef="OneD" unitRef="INR" decimals="-5">283300000.00</in-bse-fin:DeferredTax>
<in-bse-fin:TaxExpense contextRef="OneD" unitRef="INR" decimals="-5">308900000.00</in-bse-fin:TaxExpense>
<in-bse-fin:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement>
<in-bse-fin:ProfitLossForPeriodFromContinuingOperations contextRef="OneD" unitRef="INR" decimals="-5">-126800000.00</in-bse-fin:ProfitLossForPeriodFromContinuingOperations>
<in-bse-fin:ProfitLossFromDiscontinuedOperationsBeforeTax contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitLossFromDiscontinuedOperationsBeforeTax>
<in-bse-fin:TaxExpenseOfDiscontinuedOperations contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:TaxExpenseOfDiscontinuedOperations>
<in-bse-fin:ProfitLossFromDiscontinuedOperationsAfterTax contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitLossFromDiscontinuedOperationsAfterTax>
<in-bse-fin:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
<in-bse-fin:ProfitLossForPeriod contextRef="OneD" unitRef="INR" decimals="-5">-126800000.00</in-bse-fin:ProfitLossForPeriod>
<in-bse-fin:OtherComprehensiveIncomeNetOfTaxes contextRef="OneD" unitRef="INR" decimals="-5">8900000.00</in-bse-fin:OtherComprehensiveIncomeNetOfTaxes>
<in-bse-fin:ComprehensiveIncomeForThePeriod contextRef="OneD" unitRef="INR" decimals="-5">-117900000.00</in-bse-fin:ComprehensiveIncomeForThePeriod>
<in-bse-fin:ProfitOrLossAttributableToOwnersOfParent contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitOrLossAttributableToOwnersOfParent>
<in-bse-fin:ProfitOrLossAttributableToNonControllingInterests contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitOrLossAttributableToNonControllingInterests>
<in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParent contextRef="OneD" unitRef="INR" decimals="-5">-115200000.00</in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParent>
<in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParentNonControllingInterests contextRef="OneD" unitRef="INR" decimals="-5">-2700000.00</in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParentNonControllingInterests>
<in-bse-fin:PaidUpValueOfEquityShareCapital contextRef="OneD" unitRef="INR" decimals="-5">61300000.00</in-bse-fin:PaidUpValueOfEquityShareCapital>
<in-bse-fin:FaceValueOfEquityShareCapital contextRef="OneD" unitRef="INRPerShare" decimals="INF">1</in-bse-fin:FaceValueOfEquityShareCapital>
<in-bse-fin:BasicEarningsLossPerShareFromContinuingOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">-2.07</in-bse-fin:BasicEarningsLossPerShareFromContinuingOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromContinuingOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">-2.07</in-bse-fin:DilutedEarningsLossPerShareFromContinuingOperations>
<in-bse-fin:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">0.00</in-bse-fin:BasicEarningsLossPerShareFromDiscontinuedOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">0.00</in-bse-fin:DilutedEarningsLossPerShareFromDiscontinuedOperations>
<in-bse-fin:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">-2.07</in-bse-fin:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" unitRef="INRPerShare" decimals="INF">-2.07</in-bse-fin:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations>
<in-bse-fin:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock contextRef="OneD">Notes:      1. The above financial results of Panacea Biotec Limited (‘the Company’ or ‘PBL’) were reviewed by the Audit Committee of the Board of Directors and approved by the Board of Directors at their meetings held on May 29, 2023 and May 30, 2023 respectively and have been audited by the statutory auditors of the Company.    2. The financial results have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards (“IND AS”) notified under the Companies (Indian Accounting Standards) Rule, 2015, as amended from time to time, specified under section 133 of the Companies Act, 2013.    3. The consolidated financial results of the Company have been prepared by consolidating the Company's financial results for the respective periods with the audited financial results of the following wholly-owned subsidiaries (“WOS”) and the Enterprises over which the Company exercises control (collectively, the Company, these subsidiaries and the enterprises hereinafter referred to as “the Group”):   (i) Indian WOS: Panacea Biotec Pharma Limited (PBPL) and Meyten Realtech Private Limited;    (ii) Overseas WOS: Panacea Biotec (International) SA, and Panacea Biotec Germany GmbH; and    (iii) Enterprises over which the Company exercises control: PanEra Biotec Private Limited and Adveta Power Private Limited.</in-bse-fin:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock>
<in-bse-fin:IsCompanyReportingMultisegmentOrSingleSegment contextRef="FourD">Multi segment</in-bse-fin:IsCompanyReportingMultisegmentOrSingleSegment>
<in-bse-fin:DateOfStartOfReportingPeriod contextRef="FourD">2022-04-01</in-bse-fin:DateOfStartOfReportingPeriod>
<in-bse-fin:DateOfEndOfReportingPeriod contextRef="FourD">2023-03-31</in-bse-fin:DateOfEndOfReportingPeriod>
<in-bse-fin:WhetherResultsAreAuditedOrUnaudited contextRef="FourD">Audited</in-bse-fin:WhetherResultsAreAuditedOrUnaudited>
<in-bse-fin:NatureOfReportStandaloneConsolidated contextRef="FourD">Consolidated</in-bse-fin:NatureOfReportStandaloneConsolidated>
<in-bse-fin:RevenueFromOperations contextRef="FourD" unitRef="INR" decimals="-5">4599500000.00</in-bse-fin:RevenueFromOperations>
<in-bse-fin:OtherIncome contextRef="FourD" unitRef="INR" decimals="-5">516600000.00</in-bse-fin:OtherIncome>
<in-bse-fin:Income contextRef="FourD" unitRef="INR" decimals="-5">5116100000.00</in-bse-fin:Income>
<in-bse-fin:CostOfMaterialsConsumed contextRef="FourD" unitRef="INR" decimals="-5">2110300000.00</in-bse-fin:CostOfMaterialsConsumed>
<in-bse-fin:PurchasesOfStockInTrade contextRef="FourD" unitRef="INR" decimals="-5">72600000.00</in-bse-fin:PurchasesOfStockInTrade>
<in-bse-fin:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade contextRef="FourD" unitRef="INR" decimals="-5">343700000.00</in-bse-fin:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade>
<in-bse-fin:EmployeeBenefitExpense contextRef="FourD" unitRef="INR" decimals="-5">1264800000.00</in-bse-fin:EmployeeBenefitExpense>
<in-bse-fin:FinanceCosts contextRef="FourD" unitRef="INR" decimals="-5">44400000.00</in-bse-fin:FinanceCosts>
<in-bse-fin:DepreciationDepletionAndAmortisationExpense contextRef="FourD" unitRef="INR" decimals="-5">391200000.00</in-bse-fin:DepreciationDepletionAndAmortisationExpense>
<in-bse-fin:OtherExpenses contextRef="FourD" unitRef="INR" decimals="-5">1787700000.00</in-bse-fin:OtherExpenses>
<in-bse-fin:Expenses contextRef="FourD" unitRef="INR" decimals="-5">6014700000.00</in-bse-fin:Expenses>
<in-bse-fin:ProfitBeforeExceptionalItemsAndTax contextRef="FourD" unitRef="INR" decimals="-5">-898600000.00</in-bse-fin:ProfitBeforeExceptionalItemsAndTax>
<in-bse-fin:ExceptionalItemsBeforeTax contextRef="FourD" unitRef="INR" decimals="-5">1026600000.00</in-bse-fin:ExceptionalItemsBeforeTax>
<in-bse-fin:ProfitBeforeTax contextRef="FourD" unitRef="INR" decimals="-5">128000000.00</in-bse-fin:ProfitBeforeTax>
<in-bse-fin:CurrentTax contextRef="FourD" unitRef="INR" decimals="-5">25600000.00</in-bse-fin:CurrentTax>
<in-bse-fin:DeferredTax contextRef="FourD" unitRef="INR" decimals="-5">439900000.00</in-bse-fin:DeferredTax>
<in-bse-fin:TaxExpense contextRef="FourD" unitRef="INR" decimals="-5">465500000.00</in-bse-fin:TaxExpense>
<in-bse-fin:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement>
<in-bse-fin:ProfitLossForPeriodFromContinuingOperations contextRef="FourD" unitRef="INR" decimals="-5">-337500000.00</in-bse-fin:ProfitLossForPeriodFromContinuingOperations>
<in-bse-fin:ProfitLossFromDiscontinuedOperationsBeforeTax contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitLossFromDiscontinuedOperationsBeforeTax>
<in-bse-fin:TaxExpenseOfDiscontinuedOperations contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:TaxExpenseOfDiscontinuedOperations>
<in-bse-fin:ProfitLossFromDiscontinuedOperationsAfterTax contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitLossFromDiscontinuedOperationsAfterTax>
<in-bse-fin:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
<in-bse-fin:ProfitLossForPeriod contextRef="FourD" unitRef="INR" decimals="-5">-337500000.00</in-bse-fin:ProfitLossForPeriod>
<in-bse-fin:OtherComprehensiveIncomeNetOfTaxes contextRef="FourD" unitRef="INR" decimals="-5">2800000.00</in-bse-fin:OtherComprehensiveIncomeNetOfTaxes>
<in-bse-fin:ComprehensiveIncomeForThePeriod contextRef="FourD" unitRef="INR" decimals="-5">-334700000.00</in-bse-fin:ComprehensiveIncomeForThePeriod>
<in-bse-fin:ProfitOrLossAttributableToOwnersOfParent contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitOrLossAttributableToOwnersOfParent>
<in-bse-fin:ProfitOrLossAttributableToNonControllingInterests contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProfitOrLossAttributableToNonControllingInterests>
<in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParent contextRef="FourD" unitRef="INR" decimals="-5">-329600000.00</in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParent>
<in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParentNonControllingInterests contextRef="FourD" unitRef="INR" decimals="-5">-5100000.00</in-bse-fin:ComprehensiveIncomeForThePeriodAttributableToOwnersOfParentNonControllingInterests>
<in-bse-fin:PaidUpValueOfEquityShareCapital contextRef="FourD" unitRef="INR" decimals="-5">61300000.00</in-bse-fin:PaidUpValueOfEquityShareCapital>
<in-bse-fin:FaceValueOfEquityShareCapital contextRef="FourD" unitRef="INRPerShare" decimals="INF">1</in-bse-fin:FaceValueOfEquityShareCapital>
<in-bse-fin:ReserveExcludingRevaluationReserves contextRef="FourD" unitRef="INR" decimals="-5">8374800000.00</in-bse-fin:ReserveExcludingRevaluationReserves>
<in-bse-fin:BasicEarningsLossPerShareFromContinuingOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">-5.51</in-bse-fin:BasicEarningsLossPerShareFromContinuingOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromContinuingOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">-5.51</in-bse-fin:DilutedEarningsLossPerShareFromContinuingOperations>
<in-bse-fin:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">0.00</in-bse-fin:BasicEarningsLossPerShareFromDiscontinuedOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">0.00</in-bse-fin:DilutedEarningsLossPerShareFromDiscontinuedOperations>
<in-bse-fin:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">-5.51</in-bse-fin:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations>
<in-bse-fin:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="FourD" unitRef="INRPerShare" decimals="INF">-5.51</in-bse-fin:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations>
<in-bse-fin:DescriptionOfOtherExpenses contextRef="OneOperatingExpenses01D">Others</in-bse-fin:DescriptionOfOtherExpenses>
<in-bse-fin:OtherExpenses contextRef="OneOperatingExpenses01D" unitRef="INR" decimals="-5">465700000.00</in-bse-fin:OtherExpenses>
<in-bse-fin:DescriptionOfOtherExpenses contextRef="FourOperatingExpenses01D">Others</in-bse-fin:DescriptionOfOtherExpenses>
<in-bse-fin:OtherExpenses contextRef="FourOperatingExpenses01D" unitRef="INR" decimals="-5">1787700000.00</in-bse-fin:OtherExpenses>
<in-bse-fin:NonControllingInterest contextRef="OneI" unitRef="INR" decimals="-5">-35000000.00</in-bse-fin:NonControllingInterest>
<in-bse-fin:PropertyPlantAndEquipment contextRef="OneI" unitRef="INR" decimals="-5">5883300000.00</in-bse-fin:PropertyPlantAndEquipment>
<in-bse-fin:CapitalWorkInProgress contextRef="OneI" unitRef="INR" decimals="-5">280100000.00</in-bse-fin:CapitalWorkInProgress>
<in-bse-fin:InvestmentProperty contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:InvestmentProperty>
<in-bse-fin:Goodwill contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:Goodwill>
<in-bse-fin:OtherIntangibleAssets contextRef="OneI" unitRef="INR" decimals="-5">116200000.00</in-bse-fin:OtherIntangibleAssets>
<in-bse-fin:IntangibleAssetsUnderDevelopment contextRef="OneI" unitRef="INR" decimals="-5">143200000.00</in-bse-fin:IntangibleAssetsUnderDevelopment>
<in-bse-fin:BiologicalAssetsOtherThanBearerPlants contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:BiologicalAssetsOtherThanBearerPlants>
<in-bse-fin:InvestmentsAccountedForUsingEquityMethod contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:InvestmentsAccountedForUsingEquityMethod>
<in-bse-fin:NoncurrentInvestments contextRef="OneI" unitRef="INR" decimals="-5">700000.00</in-bse-fin:NoncurrentInvestments>
<in-bse-fin:TradeReceivablesNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:TradeReceivablesNoncurrent>
<in-bse-fin:LoansNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">3000000.00</in-bse-fin:LoansNoncurrent>
<in-bse-fin:OtherNoncurrentFinancialAssets contextRef="OneI" unitRef="INR" decimals="-5">48900000.00</in-bse-fin:OtherNoncurrentFinancialAssets>
<in-bse-fin:NoncurrentFinancialAssets contextRef="OneI" unitRef="INR" decimals="-5">52600000.00</in-bse-fin:NoncurrentFinancialAssets>
<in-bse-fin:DeferredTaxAssetsNet contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:DeferredTaxAssetsNet>
<in-bse-fin:OtherNoncurrentAssets contextRef="OneI" unitRef="INR" decimals="-5">553100000.00</in-bse-fin:OtherNoncurrentAssets>
<in-bse-fin:NoncurrentAssets contextRef="OneI" unitRef="INR" decimals="-5">7028500000.00</in-bse-fin:NoncurrentAssets>
<in-bse-fin:Inventories contextRef="OneI" unitRef="INR" decimals="-5">2020900000.00</in-bse-fin:Inventories>
<in-bse-fin:CurrentInvestments contextRef="OneI" unitRef="INR" decimals="-5">134200000.00</in-bse-fin:CurrentInvestments>
<in-bse-fin:TradeReceivablesCurrent contextRef="OneI" unitRef="INR" decimals="-5">600900000.00</in-bse-fin:TradeReceivablesCurrent>
<in-bse-fin:CashAndCashEquivalents contextRef="OneI" unitRef="INR" decimals="-5">398500000.00</in-bse-fin:CashAndCashEquivalents>
<in-bse-fin:BankBalanceOtherThanCashAndCashEquivalents contextRef="OneI" unitRef="INR" decimals="-5">1861400000.00</in-bse-fin:BankBalanceOtherThanCashAndCashEquivalents>
<in-bse-fin:LoansCurrent contextRef="OneI" unitRef="INR" decimals="-5">15800000.00</in-bse-fin:LoansCurrent>
<in-bse-fin:OtherCurrentFinancialAssets contextRef="OneI" unitRef="INR" decimals="-5">591400000.00</in-bse-fin:OtherCurrentFinancialAssets>
<in-bse-fin:CurrentFinancialAssets contextRef="OneI" unitRef="INR" decimals="-5">3602200000.00</in-bse-fin:CurrentFinancialAssets>
<in-bse-fin:CurrentTaxAssets contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:CurrentTaxAssets>
<in-bse-fin:OtherCurrentAssets contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherCurrentAssets>
<in-bse-fin:CurrentAssets contextRef="OneI" unitRef="INR" decimals="-5">5623100000.00</in-bse-fin:CurrentAssets>
<in-bse-fin:NoncurrentAssetsClassifiedAsHeldForSale contextRef="OneI" unitRef="INR" decimals="-5">60000000.00</in-bse-fin:NoncurrentAssetsClassifiedAsHeldForSale>
<in-bse-fin:RegulatoryDeferralAccountDebitBalancesAndRelatedDeferredTaxAssets contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:RegulatoryDeferralAccountDebitBalancesAndRelatedDeferredTaxAssets>
<in-bse-fin:Assets contextRef="OneI" unitRef="INR" decimals="-5">12711600000.00</in-bse-fin:Assets>
<in-bse-fin:EquityShareCapital contextRef="OneI" unitRef="INR" decimals="-5">61300000.00</in-bse-fin:EquityShareCapital>
<in-bse-fin:OtherEquity contextRef="OneI" unitRef="INR" decimals="-5">8374800000.00</in-bse-fin:OtherEquity>
<in-bse-fin:EquityAttributableToOwnersOfParent contextRef="OneI" unitRef="INR" decimals="-5">8436100000.00</in-bse-fin:EquityAttributableToOwnersOfParent>
<in-bse-fin:Equity contextRef="OneI" unitRef="INR" decimals="-5">8401100000.00</in-bse-fin:Equity>
<in-bse-fin:BorrowingsNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">201600000.00</in-bse-fin:BorrowingsNoncurrent>
<in-bse-fin:TradePayablesNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:TradePayablesNoncurrent>
<in-bse-fin:NoncurrentFinancialLiabilities contextRef="OneI" unitRef="INR" decimals="-5">201600000.00</in-bse-fin:NoncurrentFinancialLiabilities>
<in-bse-fin:ProvisionsNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">265500000.00</in-bse-fin:ProvisionsNoncurrent>
<in-bse-fin:DeferredTaxLiabilitiesNet contextRef="OneI" unitRef="INR" decimals="-5">203700000.00</in-bse-fin:DeferredTaxLiabilitiesNet>
<in-bse-fin:DeferredGovernmentGrantsNoncurrent contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:DeferredGovernmentGrantsNoncurrent>
<in-bse-fin:OtherNoncurrentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">321400000.00</in-bse-fin:OtherNoncurrentLiabilities>
<in-bse-fin:NoncurrentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">992200000.00</in-bse-fin:NoncurrentLiabilities>
<in-bse-fin:BorrowingsCurrent contextRef="OneI" unitRef="INR" decimals="-5">600000.00</in-bse-fin:BorrowingsCurrent>
<in-bse-fin:TradePayablesCurrent contextRef="OneI" unitRef="INR" decimals="-5">1773200000.00</in-bse-fin:TradePayablesCurrent>
<in-bse-fin:OtherCurrentFinancialLiabilities contextRef="OneI" unitRef="INR" decimals="-5">203600000.00</in-bse-fin:OtherCurrentFinancialLiabilities>
<in-bse-fin:CurrentFinancialLiabilities contextRef="OneI" unitRef="INR" decimals="-5">1977400000.00</in-bse-fin:CurrentFinancialLiabilities>
<in-bse-fin:OtherCurrentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">952900000.00</in-bse-fin:OtherCurrentLiabilities>
<in-bse-fin:ProvisionsCurrent contextRef="OneI" unitRef="INR" decimals="-5">361400000.00</in-bse-fin:ProvisionsCurrent>
<in-bse-fin:CurrentTaxLiabilities contextRef="OneI" unitRef="INR" decimals="-5">5600000.00</in-bse-fin:CurrentTaxLiabilities>
<in-bse-fin:DeferredGovernmentGrantsCurrent contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:DeferredGovernmentGrantsCurrent>
<in-bse-fin:CurrentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">3297300000.00</in-bse-fin:CurrentLiabilities>
<in-bse-fin:LiabilitiesDirectlyAssociatedWithAssetsInDisposalGroupClassifiedAsHeldForSale contextRef="OneI" unitRef="INR" decimals="-5">21000000.00</in-bse-fin:LiabilitiesDirectlyAssociatedWithAssetsInDisposalGroupClassifiedAsHeldForSale>
<in-bse-fin:RegulatoryDeferralAccountCreditBalancesAndRelatedDeferredTaxLiability contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:RegulatoryDeferralAccountCreditBalancesAndRelatedDeferredTaxLiability>
<in-bse-fin:Liabilities contextRef="OneI" unitRef="INR" decimals="-5">4310500000.00</in-bse-fin:Liabilities>
<in-bse-fin:EquityAndLiabilities contextRef="OneI" unitRef="INR" decimals="-5">12711600000.00</in-bse-fin:EquityAndLiabilities>
<in-bse-fin:DisclosureOfNotesOnAssetsAndLiabilitiesExplanatoryTextBlock contextRef="OneD">4. The Board of Directors of the Company’s wholly-owned subsidiary, viz. Meyten Realtech Private Limited (“Meyten” or “Resulting Company”) and the Company’s erstwhile wholly-owned subsidiary, Radhika Heights Limited (“RHL”) and Cabana Structures Limited, a wholly owned subsidiary of RHL, in their respective meetings held on August 29, 2020, approved a Scheme of Arrangement (“Scheme”) for inter-alia, demerger of the Demerged Undertaking comprising of Specified Leasing Business including its immovable property belonging to RHL with and into Meyten w.e.f. the Appointed Date i.e. April 01, 2020 (“Appointed Date”), which was filed with the Hon’ble National Company Law Tribunal, Chandigarh (“NCLT”) on December 15, 2020. The Scheme has been approved by Hon’ble NCLT vide its order dated January 18, 2023 and necessary forms have been filed with Registrar of Companies, Punjab &amp; Chandigarh (“RoC”) on March 18, 2023. The ROC has issued Certificate dated March 24, 2023 on registration of the Order and making the Scheme effective, with March 24, 2023 as the Effective Date. Upon the Scheme coming into effect, Meyten has recorded all the assets, liabilities and reserves of the Demerged Undertaking at book value as appearing in the books of RHL as on the date from the Appointed Date. The consolidated financial results of the Company for the financial year ended March 31, 2023 includes assets of Rs. 3,484 Lakh, liabilities of Rs. 671 lakh and capital reserve of Rs.2,699 lakh pertaining to Meyten.   5. For the year ended March 31, 2023, the Company has incurred loss (before tax and exceptional items) of Rs.6,275 lakh (year ended March 31, 2022: loss of Rs.9,358 lakh) and the Group has incurred a loss (before tax and exceptional items) of Rs.8,986 lakh (year ended March 31, 2022: loss of Rs.22,685 lakh). In March, 2022, the Group had sold its Pharmaceutical Formulations Brands in India and Nepal, as explained in Note 6 below, for consideration of Rs.187,200 lakh, which enabled the Group to repay its outstanding dues of Non-Convertible Debenture (NCDs) and retain sufficient surplus to fund its existing projects and operations and also help the Group to enter new market and expediting development of new products. The surplus funds with the Group has also strengthened the working capital position and scaling up its pharmaceutical formulations business in international markets including ROW countries, USA / EU, etc. and to pursue other business opportunities. The Company has already received higher long-term business orders for vaccines from key institutional customers. Based on these measures and continuous efforts to improve the business performance, the management has prepared the financial results on going concern basis</in-bse-fin:DisclosureOfNotesOnAssetsAndLiabilitiesExplanatoryTextBlock>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentRevenue01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentRevenue contextRef="OneReportableSegmentRevenue01D" unitRef="INR" decimals="-5">539200000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentRevenue02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentRevenue contextRef="OneReportableSegmentRevenue02D" unitRef="INR" decimals="-5">750100000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:DescriptionOfReportableSegment contextRef="FourReportableSegmentRevenue01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentRevenue contextRef="FourReportableSegmentRevenue01D" unitRef="INR" decimals="-5">2029600000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:DescriptionOfReportableSegment contextRef="FourReportableSegmentRevenue02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentRevenue contextRef="FourReportableSegmentRevenue02D" unitRef="INR" decimals="-5">2569900000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:SegmentRevenue contextRef="OneD" unitRef="INR" decimals="-5">1289300000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:SegmentRevenue contextRef="FourD" unitRef="INR" decimals="-5">4599500000.00</in-bse-fin:SegmentRevenue>
<in-bse-fin:InterSegmentRevenue contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:InterSegmentRevenue>
<in-bse-fin:InterSegmentRevenue contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:InterSegmentRevenue>
<in-bse-fin:SegmentRevenueFromOperations contextRef="OneD" unitRef="INR" decimals="-5">1289300000.00</in-bse-fin:SegmentRevenueFromOperations>
<in-bse-fin:SegmentRevenueFromOperations contextRef="FourD" unitRef="INR" decimals="-5">4599500000.00</in-bse-fin:SegmentRevenueFromOperations>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentResults01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneReportableSegmentResults01D" unitRef="INR" decimals="-5">89500000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentResults02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneReportableSegmentResults02D" unitRef="INR" decimals="-5">92600000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:DescriptionOfReportableSegment contextRef="FourReportableSegmentResults01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourReportableSegmentResults01D" unitRef="INR" decimals="-5">776800000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:DescriptionOfReportableSegment contextRef="FourReportableSegmentResults02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourReportableSegmentResults02D" unitRef="INR" decimals="-5">-648800000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneD" unitRef="INR" decimals="-5">182100000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourD" unitRef="INR" decimals="-5">128000000.00</in-bse-fin:SegmentProfitLossBeforeTaxAndFinanceCosts>
<in-bse-fin:SegmentFinanceCosts contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:SegmentFinanceCosts>
<in-bse-fin:SegmentFinanceCosts contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:SegmentFinanceCosts>
<in-bse-fin:OtherUnallocableExpenditureNetOffUnAllocableIncome contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherUnallocableExpenditureNetOffUnAllocableIncome>
<in-bse-fin:DisclosureOfNotesOnSegmentsExplanatoryTextBlock contextRef="OneD">6. During the year, the Group has recognised revenue of Rs.10,266 lakh, out of the deferred consideration of Rs.19,579 lakh from sale of domestic pharmaceutical brands, under “Exceptional Item” in the statement of the profit and loss. In previous year, the Group had recognised revenue of Rs.167,621 lakh, which is shown as an “Exceptional Item”, out of the total consideration of Rs.187,200 lakh plus applicable taxes pertaining to the sale of PBPL’s domestic pharmaceutical formulations brands in India and Nepal. The remaining deferred consideration of Rs.9,313 lakh would be recognised as revenue in subsequent years and is shown as Contract Liability.    7. The Company publishes standalone financial results along with the consolidated financial results. In accordance with Ind AS 108, ‘Operating Segments’, the management has disclosed the segment information in the unaudited consolidated financial results. Accordingly, the segment information is given in the audited consolidated financial results of the Group for the quarter and year ended March 31, 2023.   8. Amounts for the quarters ended March 31, 2023 and March 31, 2022 represent the balancing amounts between the audited amounts for the full financial year and published year to date amounts upto the third quarter of the respective financial years, which had been subjected only to limited review.   9. The necessary certificate / report in respect of the above results in terms of requirement of Regulation 33 of the SEBI (Listing Obligations and Other Disclosure Requirements) Regulations, 2015, has been placed before the Board of Directors.   10. Previous period amounts have been regrouped/ reclassified in compliance with IND-AS to make them comparable with those of current period/ year.   11. ‘0’ under “Rs. in Lakh” represents amount less than Rs.50,000. Further, the figures shown in the tables may not exactly add up due to rounding off.   12. The above results are also available on the Company’s website https://www.panaceabiotec.com</in-bse-fin:DisclosureOfNotesOnSegmentsExplanatoryTextBlock>
<in-bse-fin:OtherUnallocableExpenditureNetOffUnAllocableIncome contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherUnallocableExpenditureNetOffUnAllocableIncome>
<in-bse-fin:SegmentProfitBeforeTax contextRef="OneD" unitRef="INR" decimals="-5">182100000.00</in-bse-fin:SegmentProfitBeforeTax>
<in-bse-fin:SegmentProfitBeforeTax contextRef="FourD" unitRef="INR" decimals="-5">128000000.00</in-bse-fin:SegmentProfitBeforeTax>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentAssets01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentAssets contextRef="OneReportableSegmentAssets01D" unitRef="INR" decimals="-5">5253600000.00</in-bse-fin:SegmentAssets>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentAssets02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentAssets contextRef="OneReportableSegmentAssets02D" unitRef="INR" decimals="-5">7398000000.00</in-bse-fin:SegmentAssets>
<in-bse-fin:SegmentAssets contextRef="OneD" unitRef="INR" decimals="-5">12651600000.00</in-bse-fin:SegmentAssets>
<in-bse-fin:UnAllocableAssets contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:UnAllocableAssets>
<in-bse-fin:NetSegmentAssets contextRef="OneI" unitRef="INR" decimals="-5">12651600000.00</in-bse-fin:NetSegmentAssets>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentLiabilities01D">Formulations</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentLiabilities contextRef="OneReportableSegmentLiabilities01I" unitRef="INR" decimals="-5">1304200000.00</in-bse-fin:SegmentLiabilities>
<in-bse-fin:DescriptionOfReportableSegment contextRef="OneReportableSegmentLiabilities02D">Vaccines</in-bse-fin:DescriptionOfReportableSegment>
<in-bse-fin:SegmentLiabilities contextRef="OneReportableSegmentLiabilities02I" unitRef="INR" decimals="-5">2985300000.00</in-bse-fin:SegmentLiabilities>
<in-bse-fin:SegmentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">4289500000.00</in-bse-fin:SegmentLiabilities>
<in-bse-fin:UnAllocableLiabilities contextRef="OneI" unitRef="INR" decimals="-5">0.00</in-bse-fin:UnAllocableLiabilities>
<in-bse-fin:NetSegmentLiabilities contextRef="OneI" unitRef="INR" decimals="-5">4289500000.00</in-bse-fin:NetSegmentLiabilities>
<in-bse-fin:AdjustmentsForFinanceCosts contextRef="FourD" unitRef="INR" decimals="-5">44400000.00</in-bse-fin:AdjustmentsForFinanceCosts>
<in-bse-fin:AdjustmentsForDecreaseIncreaseInInventories contextRef="FourD" unitRef="INR" decimals="-5">106300000.00</in-bse-fin:AdjustmentsForDecreaseIncreaseInInventories>
<in-bse-fin:AdjustmentsForDecreaseIncreaseInTradeReceivablesCurrent contextRef="FourD" unitRef="INR" decimals="-5">68900000.00</in-bse-fin:AdjustmentsForDecreaseIncreaseInTradeReceivablesCurrent>
<in-bse-fin:AdjustmentsForDecreaseIncreaseInTradeReceivablesNoncurrent contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForDecreaseIncreaseInTradeReceivablesNoncurrent>
<in-bse-fin:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="FourD" unitRef="INR" decimals="-5">20317000.00</in-bse-fin:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
<in-bse-fin:AdjustmentsForDecreaseIncreaseInOtherNoncurrentAssets contextRef="FourD" unitRef="INR" decimals="-5">-352758000.00</in-bse-fin:AdjustmentsForDecreaseIncreaseInOtherNoncurrentAssets>
<in-bse-fin:AdjustmentsForOtherFinancialAssetsNoncurrent contextRef="FourD" unitRef="INR" decimals="-5">-799207000.00</in-bse-fin:AdjustmentsForOtherFinancialAssetsNoncurrent>
<in-bse-fin:AdjustmentsForOtherFinancialAssetsCurrent contextRef="FourD" unitRef="INR" decimals="-5">813651000.00</in-bse-fin:AdjustmentsForOtherFinancialAssetsCurrent>
<in-bse-fin:AdjustmentsForOtherBankBalances contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForOtherBankBalances>
<in-bse-fin:AdjustmentsForIncreaseDecreaseInTradePayablesCurrent contextRef="FourD" unitRef="INR" decimals="-5">-217644000.00</in-bse-fin:AdjustmentsForIncreaseDecreaseInTradePayablesCurrent>
<in-bse-fin:AdjustmentsForIncreaseDecreaseInTradePayablesNoncurrent contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForIncreaseDecreaseInTradePayablesNoncurrent>
<in-bse-fin:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="FourD" unitRef="INR" decimals="-5">-2998325000.00</in-bse-fin:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
<in-bse-fin:AdjustmentsForIncreaseDecreaseInOtherNoncurrentLiabilities contextRef="FourD" unitRef="INR" decimals="-5">-134487000.00</in-bse-fin:AdjustmentsForIncreaseDecreaseInOtherNoncurrentLiabilities>
<in-bse-fin:AdjustmentsForDepreciationAndAmortisationExpense contextRef="FourD" unitRef="INR" decimals="-5">391200000.00</in-bse-fin:AdjustmentsForDepreciationAndAmortisationExpense>
<in-bse-fin:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
<in-bse-fin:AdjustmentsForProvisionsCurrent contextRef="FourD" unitRef="INR" decimals="-5">-11741000.00</in-bse-fin:AdjustmentsForProvisionsCurrent>
<in-bse-fin:AdjustmentsForProvisionsNoncurrent contextRef="FourD" unitRef="INR" decimals="-5">-26094000.00</in-bse-fin:AdjustmentsForProvisionsNoncurrent>
<in-bse-fin:AdjustmentsForOtherFinancialLiabilitiesCurrent contextRef="FourD" unitRef="INR" decimals="-5">151859000.00</in-bse-fin:AdjustmentsForOtherFinancialLiabilitiesCurrent>
<in-bse-fin:AdjustmentsForOtherFinancialLiabilitiesNoncurrent contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForOtherFinancialLiabilitiesNoncurrent>
<in-bse-fin:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="FourD" unitRef="INR" decimals="-5">35300000.00</in-bse-fin:AdjustmentsForUnrealisedForeignExchangeLossesGains>
<in-bse-fin:AdjustmentsForDividendIncome contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForDividendIncome>
<in-bse-fin:AdjustmentsForInterestIncome contextRef="FourD" unitRef="INR" decimals="-5">135000000.00</in-bse-fin:AdjustmentsForInterestIncome>
<in-bse-fin:AdjustmentsForSharebasedPayments contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForSharebasedPayments>
<in-bse-fin:AdjustmentsForFairValueGainsLosses contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForFairValueGainsLosses>
<in-bse-fin:AdjustmentsForUndistributedProfitsOfAssociates contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:AdjustmentsForUndistributedProfitsOfAssociates>
<in-bse-fin:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow contextRef="FourD" unitRef="INR" decimals="-5">-53000000.00</in-bse-fin:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow>
<in-bse-fin:OtherAdjustmentsToReconcileProfitLoss contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherAdjustmentsToReconcileProfitLoss>
<in-bse-fin:OtherAdjustmentsForNoncashItems contextRef="FourD" unitRef="INR" decimals="-5">-1241500000.00</in-bse-fin:OtherAdjustmentsForNoncashItems>
<in-bse-fin:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships>
<in-bse-fin:AdjustmentsForReconcileProfitLoss contextRef="FourD" unitRef="INR" decimals="-5">-4337830000.00</in-bse-fin:AdjustmentsForReconcileProfitLoss>
<in-bse-fin:CashFlowsFromUsedInOperations contextRef="FourD" unitRef="INR" decimals="-5">-4209830000.00</in-bse-fin:CashFlowsFromUsedInOperations>
<in-bse-fin:DividendsReceivedClassifiedAsOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:DividendsReceivedClassifiedAsOperatingActivities>
<in-bse-fin:InterestPaidClassifiedAsOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:InterestPaidClassifiedAsOperatingActivities>
<in-bse-fin:InterestReceivedClassifiedAsOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:InterestReceivedClassifiedAsOperatingActivities>
<in-bse-fin:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">24800000.00</in-bse-fin:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
<in-bse-fin:CashFlowsFromUsedInOperatingActivities contextRef="FourD" unitRef="INR" decimals="-5">-4234630000.00</in-bse-fin:CashFlowsFromUsedInOperatingActivities>
<in-bse-fin:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
<in-bse-fin:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
<in-bse-fin:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
<in-bse-fin:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
<in-bse-fin:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities>
<in-bse-fin:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities>
<in-bse-fin:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships>
<in-bse-fin:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships>
<in-bse-fin:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">395100000.00</in-bse-fin:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">409500000.00</in-bse-fin:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromSalesOfInvestmentPropertyClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromSalesOfInvestmentPropertyClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfInvestmentPropertyClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfInvestmentPropertyClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromSalesOfIntangibleAssetsUnderDevelopment contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromSalesOfIntangibleAssetsUnderDevelopment>
<in-bse-fin:PurchaseOfIntangibleAssetsUnderDevelopment contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfIntangibleAssetsUnderDevelopment>
<in-bse-fin:ProceedsFromSalesOfGoodwillClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromSalesOfGoodwillClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfGoodwillClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfGoodwillClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromSalesOfOtherLongTermAssetsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromSalesOfOtherLongTermAssetsClassifiedAsInvestingActivities>
<in-bse-fin:PurchaseOfOtherLongTermAssetsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PurchaseOfOtherLongTermAssetsClassifiedAsInvestingActivities>
<in-bse-fin:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
<in-bse-fin:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
<in-bse-fin:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities>
<in-bse-fin:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities>
<in-bse-fin:DividendsReceivedClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:DividendsReceivedClassifiedAsInvestingActivities>
<in-bse-fin:InterestReceivedClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">115600000.00</in-bse-fin:InterestReceivedClassifiedAsInvestingActivities>
<in-bse-fin:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
<in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">4202100000.00</in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities>
<in-bse-fin:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities>
<in-bse-fin:CashFlowsFromUsedInInvestingActivities contextRef="FourD" unitRef="INR" decimals="-5">4303300000.00</in-bse-fin:CashFlowsFromUsedInInvestingActivities>
<in-bse-fin:ProceedsFromChangesInOwnershipInterestsInSubsidiaries contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromChangesInOwnershipInterestsInSubsidiaries>
<in-bse-fin:PaymentsFromChangesInOwnershipInterestsInSubsidiaries contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PaymentsFromChangesInOwnershipInterestsInSubsidiaries>
<in-bse-fin:ProceedsFromIssuingSharesClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromIssuingSharesClassifiedAsFinancingActivities>
<in-bse-fin:ProceedsFromIssuingOtherEquityInstruments contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromIssuingOtherEquityInstruments>
<in-bse-fin:PaymentsToAcquireOrRedeemEntitysShares contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PaymentsToAcquireOrRedeemEntitysShares>
<in-bse-fin:PaymentsOfOtherEquityInstruments contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PaymentsOfOtherEquityInstruments>
<in-bse-fin:ProceedsFromExerciseOfStockOptions contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromExerciseOfStockOptions>
<in-bse-fin:ProceedsFromIssuingDebenturesNotesBondsEtc contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromIssuingDebenturesNotesBondsEtc>
<in-bse-fin:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
<in-bse-fin:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">147800000.00</in-bse-fin:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
<in-bse-fin:PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities>
<in-bse-fin:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
<in-bse-fin:DividendsPaidClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:DividendsPaidClassifiedAsFinancingActivities>
<in-bse-fin:InterestPaidClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">36000000.00</in-bse-fin:InterestPaidClassifiedAsFinancingActivities>
<in-bse-fin:IncomeTaxesPaidRefundClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:IncomeTaxesPaidRefundClassifiedAsFinancingActivities>
<in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
<in-bse-fin:CashFlowsFromUsedInFinancingActivities contextRef="FourD" unitRef="INR" decimals="-5">-183800000.00</in-bse-fin:CashFlowsFromUsedInFinancingActivities>
<in-bse-fin:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="FourD" unitRef="INR" decimals="-5">-115130000.00</in-bse-fin:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<in-bse-fin:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="FourD" unitRef="INR" decimals="-5">10100000.00</in-bse-fin:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<in-bse-fin:IncreaseDecreaseInCashAndCashEquivalents contextRef="FourD" unitRef="INR" decimals="-5">-105030000.00</in-bse-fin:IncreaseDecreaseInCashAndCashEquivalents>
<in-bse-fin:CashAndCashEquivalentsCashFlowStatement contextRef="FourD" unitRef="INR" decimals="-5">503500000.00</in-bse-fin:CashAndCashEquivalentsCashFlowStatement>
<in-bse-fin:CashAndCashEquivalentsCashFlowStatement contextRef="FourD" unitRef="INR" decimals="-5">398470000.00</in-bse-fin:CashAndCashEquivalentsCashFlowStatement>
<in-bse-fin:DescriptionOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="OneItemsThatWillNotBeReclassifiedToProfitAndLoss01D">Items that will not be reclassified to profit or loss</in-bse-fin:DescriptionOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="OneItemsThatWillNotBeReclassifiedToProfitAndLoss01D" unitRef="INR" decimals="-5">-6600000.00</in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:DescriptionOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="FourItemsThatWillNotBeReclassifiedToProfitAndLoss01D">Items that will not be reclassified to profit or loss</in-bse-fin:DescriptionOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="FourItemsThatWillNotBeReclassifiedToProfitAndLoss01D" unitRef="INR" decimals="-5">-13700000.00</in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="OneD" unitRef="INR" decimals="-5">-6600000.00</in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss contextRef="FourD" unitRef="INR" decimals="-5">-13700000.00</in-bse-fin:AmountOfItemThatWillNotBeReclassifiedToProfitAndLoss>
<in-bse-fin:IncomeTaxRelatingToItmesThatWillNotBeReclassifiedToProfitOrLoss contextRef="OneD" unitRef="INR" decimals="-5">2800000.00</in-bse-fin:IncomeTaxRelatingToItmesThatWillNotBeReclassifiedToProfitOrLoss>
<in-bse-fin:IncomeTaxRelatingToItmesThatWillNotBeReclassifiedToProfitOrLoss contextRef="FourD" unitRef="INR" decimals="-5">1300000.00</in-bse-fin:IncomeTaxRelatingToItmesThatWillNotBeReclassifiedToProfitOrLoss>
<in-bse-fin:DescriptionOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="OneItemsThatWillBeReclassifiedToProfitAndLoss01D">Items that will be reclassified to profit or loss</in-bse-fin:DescriptionOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="OneItemsThatWillBeReclassifiedToProfitAndLoss01D" unitRef="INR" decimals="-5">18300000.00</in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:DescriptionOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="FourItemsThatWillBeReclassifiedToProfitAndLoss01D">Items that will be reclassified to profit or loss</in-bse-fin:DescriptionOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="FourItemsThatWillBeReclassifiedToProfitAndLoss01D" unitRef="INR" decimals="-5">17800000.00</in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="OneD" unitRef="INR" decimals="-5">18300000.00</in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss contextRef="FourD" unitRef="INR" decimals="-5">17800000.00</in-bse-fin:AmountOfItemThatWillBeReclassifiedToProfitAndLoss>
<in-bse-fin:IncomeTaxRelatingToItmesThatWillBeReclassifiedToProfitOrLoss contextRef="OneD" unitRef="INR" decimals="-5">0.00</in-bse-fin:IncomeTaxRelatingToItmesThatWillBeReclassifiedToProfitOrLoss>
<in-bse-fin:IncomeTaxRelatingToItmesThatWillBeReclassifiedToProfitOrLoss contextRef="FourD" unitRef="INR" decimals="-5">0.00</in-bse-fin:IncomeTaxRelatingToItmesThatWillBeReclassifiedToProfitOrLoss>
</xbrli:xbrl>